首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   155055篇
  免费   10817篇
  国内免费   591篇
耳鼻咽喉   1761篇
儿科学   3860篇
妇产科学   2598篇
基础医学   20383篇
口腔科学   3377篇
临床医学   15091篇
内科学   32306篇
皮肤病学   3234篇
神经病学   14372篇
特种医学   6918篇
外国民族医学   14篇
外科学   24992篇
综合类   1932篇
一般理论   109篇
预防医学   11459篇
眼科学   3277篇
药学   10052篇
中国医学   235篇
肿瘤学   10493篇
  2023年   803篇
  2022年   583篇
  2021年   2568篇
  2020年   2024篇
  2019年   3062篇
  2018年   3548篇
  2017年   2794篇
  2016年   3092篇
  2015年   3556篇
  2014年   5063篇
  2013年   6823篇
  2012年   10326篇
  2011年   10983篇
  2010年   6284篇
  2009年   5988篇
  2008年   9730篇
  2007年   10172篇
  2006年   10083篇
  2005年   10125篇
  2004年   9295篇
  2003年   8593篇
  2002年   8244篇
  2001年   2125篇
  2000年   1781篇
  1999年   2002篇
  1998年   1654篇
  1997年   1289篇
  1996年   1075篇
  1995年   1215篇
  1994年   1101篇
  1993年   990篇
  1992年   1267篇
  1991年   1187篇
  1990年   1027篇
  1989年   972篇
  1988年   899篇
  1987年   877篇
  1986年   879篇
  1985年   860篇
  1984年   910篇
  1983年   781篇
  1982年   938篇
  1981年   836篇
  1980年   719篇
  1979年   646篇
  1978年   643篇
  1977年   516篇
  1976年   489篇
  1974年   503篇
  1973年   439篇
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
1.
2.
Jones type fifth metatarsal fractures pose a challenge to the foot and ankle surgeon, given documented high nonunion rates as well as high complication rates including hardware prominence, nerve injury, and screw breakage for existing treatment modalities including screw and plantar plate fixation. We call for the design of innovative Jones-fracture specific implants which contour to the natural curve of the fifth metatarsal. Future research should aim to expand upon existing literature for Jones fracture fixation and evaluate efficacy of novel implants which are designed to address unacceptably high complication rates for existing treatment modalities.  相似文献   
3.
Graefe's Archive for Clinical and Experimental Ophthalmology - To compare the intraocular pressure (IOP)–lowering effects of netarsudil on goniotomy-treated eyes versus...  相似文献   
4.
Breeze  Penny  Gray  Laura A.  Thomas  Chloe  Bates  Sarah E.  Brennan  Alan 《Quality of life research》2022,31(11):3283-3292
Quality of Life Research - To estimate the association between changes in BMI and changes in Health-Related Quality of Life (EQ-5D-3L). The WRAP trial was a multicentre, randomised controlled trial...  相似文献   
5.
Journal of Artificial Organs - An in-vitro study was conducted to investigate the general feasibility of using only one pumping chamber of the SynCardia total artificial heart (TAH) as a...  相似文献   
6.
Tobacco smoking is associated with a substantially increased risk of postoperative complications. The peri-operative period offers a unique opportunity to support patients to stop tobacco smoking, avoid complications and improve long-term health. This systematic review provides an up-to-date summary of the evidence for tobacco cessation interventions in surgical patients. We conducted a systematic search of randomised controlled trials of tobacco cessation interventions in the peri-operative period. Quantitative synthesis of the abstinence outcomes data was by random-effects meta-analysis. The primary outcome of the meta-analysis was abstinence at the time of surgery, and the secondary outcome was abstinence at 12 months. Thirty-eight studies are included in the review (7310 randomised participants) and 26 studies are included in the meta-analysis (5969 randomised participants). Studies were pooled for subgroup analysis in two ways: by the timing of intervention delivery within the peri-operative period and by the intensity of the intervention protocol. We judged the quality of evidence as moderate, reflecting the degree of heterogeneity and the high risk of bias. Overall, peri-operative tobacco cessation interventions increased successful abstinence both at the time of surgery, risk ratio (95%CI) 1.48 (1.20–1.83), number needed to treat 7; and 12 months after surgery, risk ratio (95%CI) 1.62 (1.29–2.03), number needed to treat 9. More work is needed to inform the design and optimal delivery of interventions that are acceptable to patients and that can be incorporated into contemporary elective and urgent surgical pathways. Future trials should use standardised outcome measures.  相似文献   
7.
The International Journal of Cardiovascular Imaging - Patients undergoing coronary artery bypass grafting (CABG) face an elevated risk of heart failure (HF) and cardiovascular (CV) death. Detailed...  相似文献   
8.
The International Journal of Cardiovascular Imaging - This study investigated the impact of bicuspid aortic valve (BAV) on valve morphology and motion as well as proximal and aortic hemodynamics...  相似文献   
9.
The Dutch Drug Rediscovery Protocol (DRUP) and the Australian Cancer Molecular Screening and Therapeutic (MoST) Program are similar nonrandomized, multidrug, pan-cancer trial platforms that aim to identify signals of clinical activity of molecularly matched targeted therapies or immunotherapies outside their approved indications. Here, we report results for advanced or metastatic cancer patients with tumors harboring cyclin D-CDK4/6 pathway alterations treated with CDK4/6 inhibitors palbociclib or ribociclib. We included adult patients that had therapy-refractory solid malignancies with the following alterations: amplifications of CDK4, CDK6, CCND1, CCND2 or CCND3, or complete loss of CDKN2A or SMARCA4. Within MoST, all patients were treated with palbociclib, whereas in DRUP, palbociclib and ribociclib were assigned to different cohorts (defined by tumor type and alteration). The primary endpoint for this combined analysis was clinical benefit, defined as confirmed objective response or stable disease ≥16 weeks. We treated 139 patients with a broad variety of tumor types; 116 with palbociclib and 23 with ribociclib. In 112 evaluable patients, the objective response rate was 0% and clinical benefit rate at 16 weeks was 15%. Median progression-free survival was 4 months (95% CI: 3-5 months), and median overall survival 5 months (95% CI: 4-6 months). In conclusion, only limited clinical activity of palbociclib and ribociclib monotherapy in patients with pretreated cancers harboring cyclin D-CDK4/6 pathway alterations was observed. Our findings indicate that monotherapy use of palbociclib or ribociclib is not recommended and that merging data of two similar precision oncology trials is feasible.  相似文献   
10.
Journal of Interventional Cardiac Electrophysiology - The study sought to assess the prognostic impact of chronic kidney disease (CKD) in patients with electrical storm (ES). ES represents a...  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号